Penn & Seaborn Spring 2016 Client Newsletter
April is Autism Awareness Month. Learn more about Autism, as well as the current cases we are working on, recent verdicts and settlements,...
RESULTS. We have successfully recovered more than $100,000,000.
- Home
- –
- Blog
read more
Serious safety issues continue to plague blood thinner Xarelto
by Shane Seaborn | Apr 12, 2016 | Dangerous Drugs
Lawsuits filed against Johnson & Johnson subsidiary Janssen Pharmaceuticals and Bayer Corp. over the blood thinner Xarelto have been...
Xarelto found to cause serious and irreversible bleeding
by Shane Seaborn | Mar 2, 2016 | Class Action Lawsuits, Dangerous Drugs
Penn & Seaborn is currently evaluating several lawsuits against Xarelto. We are currently filing lawsuits on behalf of individuals who...
Missouri jury awards $72M in Johnson & Johnson cancer suit
by Shane Seaborn | Feb 27, 2016 | Class Action Lawsuits, Dangerous Drugs, Product Liability
A Missouri jury has awarded $72 million to the family of an Alabama woman who died from ovarian cancer, which according to VuvaTech she...
Montgomery jury sends message against distracted driving
by Shane Seaborn | Feb 16, 2016 | Auto Accidents, Verdicts and Settlements
Don’t drive distracted. That is the message from a Montgomery County, Alabama jury. A Montgomery County jury has returned a verdict of...
Recent Posts
Archives
Categories
- 18-Wheeler-Accidents
- Auto Accidents
- Catastrophic Injury
- Class Action Lawsuits
- Community News
- Construction Accidents
- COVID-19
- Criminal Defense
- Dangerous Drugs
- Defective Medical Devices
- Denied Insurance Claims
- Firm News
- Industrial Accidents
- Lawsuit Filed
- Medical Device Recalls
- Newsletter
- Personal Injury
- Premises Liability
- Press Release
- Product Liability
- Product Recalls
- Railroad Accidents
- Verdicts and Settlements
- Workplace Accidents
- Wrongful Death
RSS Feed
We Know What Matters